301 related articles for article (PubMed ID: 25009787)
1. Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms.
Oh CJ; Park S; Kim JY; Kim HJ; Jeoung NH; Choi YK; Go Y; Park KG; Lee IK
Redox Biol; 2014; 2():855-64. PubMed ID: 25009787
[TBL] [Abstract][Full Text] [Related]
2. Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia.
Kim JY; Cho HJ; Sir JJ; Kim BK; Hur J; Youn SW; Yang HM; Jun SI; Park KW; Hwang SJ; Kwon YW; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Cardiovasc Res; 2009 Jun; 82(3):550-60. PubMed ID: 19234301
[TBL] [Abstract][Full Text] [Related]
3. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
Choi SH; Park S; Oh CJ; Leem J; Park KG; Lee IK
Vascul Pharmacol; 2015 Oct; 73():11-9. PubMed ID: 26187356
[TBL] [Abstract][Full Text] [Related]
5. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
Oh CJ; Kim JY; Choi YK; Kim HJ; Jeong JY; Bae KH; Park KG; Lee IK
PLoS One; 2012; 7(10):e45870. PubMed ID: 23056222
[TBL] [Abstract][Full Text] [Related]
6. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies.
Gopal S; Mikulskis A; Gold R; Fox RJ; Dawson KT; Amaravadi L
Mult Scler; 2017 Dec; 23(14):1875-1883. PubMed ID: 28156185
[TBL] [Abstract][Full Text] [Related]
7. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
8. Activation of Nrf2 by dimethyl fumarate improves vascular calcification.
Ha CM; Park S; Choi YK; Jeong JY; Oh CJ; Bae KH; Lee SJ; Kim JH; Park KG; Jun do Y; Lee IK
Vascul Pharmacol; 2014 Oct; 63(1):29-36. PubMed ID: 25135648
[TBL] [Abstract][Full Text] [Related]
9. Activation of M3AChR (Type 3 Muscarinic Acetylcholine Receptor) and Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling by Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching and Vascular Remodeling.
He X; Deng J; Yu XJ; Yang S; Yang Y; Zang WJ
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2649-2664. PubMed ID: 32938216
[TBL] [Abstract][Full Text] [Related]
10. Zedoarondiol Attenuates Endothelial Cells Injury Induced by Oxidized Low-Density Lipoprotein via Nrf2 Activation.
Mao H; Tao T; Wang X; Liu M; Song D; Liu X; Shi D
Cell Physiol Biochem; 2018; 48(4):1468-1479. PubMed ID: 30064139
[TBL] [Abstract][Full Text] [Related]
11. Linagliptin protects rat carotid artery from balloon injury and activates the NRF2 antioxidant pathway.
Si J; Meng R; Gao P; Hui F; Li Y; Liu X; Yang B
Exp Anim; 2019 Feb; 68(1):81-90. PubMed ID: 30369549
[TBL] [Abstract][Full Text] [Related]
12. Role of Pin1 in neointima formation: down-regulation of Nrf2-dependent heme oxygenase-1 expression by Pin1.
Kim SE; Lee MY; Lim SC; Hien TT; Kim JW; Ahn SG; Yoon JH; Kim SK; Choi HS; Kang KW
Free Radic Biol Med; 2010 Jun; 48(12):1644-53. PubMed ID: 20307651
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo.
Levonen AL; Inkala M; Heikura T; Jauhiainen S; Jyrkkänen HK; Kansanen E; Määttä K; Romppanen E; Turunen P; Rutanen J; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):741-7. PubMed ID: 17255530
[TBL] [Abstract][Full Text] [Related]
14. Atractylenolide III attenuates bleomycin-induced experimental pulmonary fibrosis and oxidative stress in rat model via Nrf2/NQO1/HO-1 pathway activation.
Huai B; Ding J
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):436-444. PubMed ID: 32762376
[TBL] [Abstract][Full Text] [Related]
15. Coptisine inhibits neointimal hyperplasia through attenuating Pak1/Pak2 signaling in vascular smooth muscle cells without retardation of re-endothelialization.
Chen Y; Jiang X; Yuan Y; Chen Y; Wei S; Yu Y; Zhou Q; Yu Y; Wang J; Liu H; Hua X; Yang Z; Chen Z; Li Y; Wang Q; Chen J; Wang Y
Atherosclerosis; 2024 Apr; 391():117480. PubMed ID: 38447436
[TBL] [Abstract][Full Text] [Related]
16. Engineering the response to vascular injury: divergent effects of deregulated E2F1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growth.
Goukassian DA; Kishore R; Krasinski K; Dolan C; Luedemann C; Yoon YS; Kearney M; Hanley A; Ma H; Asahara T; Isner JM; Losordo DW
Circ Res; 2003 Jul; 93(2):162-9. PubMed ID: 12829616
[TBL] [Abstract][Full Text] [Related]
17. NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease.
Jin D; Lin L; Xie Y; Jia M; Qiu H; Xun K
FASEB J; 2022 Jan; 36(1):e22098. PubMed ID: 34918390
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression.
Selvendiran K; Kuppusamy ML; Bratasz A; Tong L; Rivera BK; Rink C; Sen CK; Kálai T; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2009 Jun; 329(3):959-66. PubMed ID: 19276401
[TBL] [Abstract][Full Text] [Related]
19. Dimethyl fumarate attenuates lipopolysaccharide-induced mitochondrial injury by activating Nrf2 pathway in cardiomyocytes.
Fu CY; Chen J; Lu XY; Zheng MZ; Wang LL; Shen YL; Chen YY
Life Sci; 2019 Oct; 235():116863. PubMed ID: 31513817
[TBL] [Abstract][Full Text] [Related]
20. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
